Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Vascular Surgery

  Free Subscription

Articles published in Circulation

Retrieve available abstracts of 122 articles:
HTML format

Single Articles

    April 2024
  1. RYMER JA, Patel MR
    Health-Related Quality of Life Instruments in Chronic Limb-Threatening Ischemia: Evolution of Defining Quality of Life in a Complex Disease State.
    Circulation. 2024;149:1254-1257.

  2. MENARD MT, Farber A, Powell RJ, Rosenfield K, et al
    Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization.
    Circulation. 2024;149:1241-1253.
    PubMed     Abstract available

  3. MAEHARA A, Sugizaki Y
    Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
    Circulation. 2024;149:1087-1089.

    March 2024
  4. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    PubMed     Abstract available

  5. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.

  6. ALTIN SE, Kwong M, Hamburg NM, Creager MA, et al
    Addressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e986-e995.
    PubMed     Abstract available

  7. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.

  8. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.

  9. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.

  10. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    PubMed     Abstract available

    February 2024
  11. CHEN Z, Zhang J, He Y
    Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:725-726.

  12. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
    Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
    Circulation. 2024;149:727-728.

  13. YAN Y, Guo J, Wang X, Wang G, et al
    Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
    PubMed     Abstract available

    Antiplatelet Therapy After PCI: The Art and Science of De-Escalation.
    Circulation. 2024;149:601-604.

  15. HOGAN SE, Debus ES, Nehler MR, Patel MR, et al
    Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.
    Circulation. 2024;149:635-637.

  16. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
    Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.067583.
    PubMed     Abstract available

  17. PETZL AM, Epstein AE, Guandalini GS
    Less Obvious Than One Might Think: Why Is There Grouped Beating?
    Circulation. 2024;149:481-483.

    November 2023
  18. NATSUAKI M, Watanabe H, Morimoto T, Yamamoto K, et al
    An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
    Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.066720.
    PubMed     Abstract available

    October 2023
  19. HONG SJ, Lee SJ, Suh Y, Yun KH, et al
    Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial.
    Circulation. 2023 Oct 25. doi: 10.1161/CIRCULATIONAHA.123.066943.
    PubMed     Abstract available

  20. HU Z, Wang C, Yuan X, Zhang S, et al
    Potential of Quantitative Flow Ratio for Selecting Target Vessels for Radial Artery Grafting: A Retrospective Observational Study.
    Circulation. 2023;148:1340-1342.

  21. BABER U, Jang Y, Oliva A, Cao D, et al
    Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: an Individual Patient Data Meta-analysis of TWILIGHT and TICO Randomized Trials.
    Circulation. 2023 Oct 23. doi: 10.1161/CIRCULATIONAHA.123.067283.
    PubMed     Abstract available

  22. RAYCHEV R, Sun JL, Schwamm L, Smith EE, et al
    Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines-Stroke Registry.
    Circulation. 2023 Oct 19. doi: 10.1161/CIRCULATIONAHA.123.066114.
    PubMed     Abstract available

  23. BIKDELI B, Erlinge D, Valgimigli M, Kastrati A, et al
    Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
    Circulation. 2023;148:1207-1219.
    PubMed     Abstract available

    September 2023
  24. JONES DA, Beirne AM, Kelham M, Rathod KS, et al
    Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial.
    Circulation. 2023 Sep 29. doi: 10.1161/CIRCULATIONAHA.123.064465.
    PubMed     Abstract available

  25. VALGIMIGLI M, Wlodarczak A, Tolg R, Merkely B, et al
    Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
    Circulation. 2023;148:989-999.
    PubMed     Abstract available

  26. HONG D, Kim SM, Lee SY, Choi KH, et al
    Prognostic Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Chronic Total Occlusion.
    Circulation. 2023;148:903-905.

    August 2023
  27. KANG DY, Ahn JM, Yun SC, Hur SH, et al
    Optical Coherence Tomography-Guided or Intravascular Ultrasound Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial.
    Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066429.
    PubMed     Abstract available

  28. ZIMMERMANN FM, Ding VY, Pijls NHJ, Piroth Z, et al
    Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
    Circulation. 2023 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.065770.
    PubMed     Abstract available

    July 2023
  29. OSHO A, Fernandes MF, Poudel R, de Lemos J, et al
    Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry.
    Circulation. 2023;148:229-240.
    PubMed     Abstract available

  30. VAN DE WERF F, Ristic AD, Averkov OV, AriasMendoza A, et al
    Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction in STREAM-2: A Randomized, Open-Label Trial.
    Circulation. 2023 Jul 13. doi: 10.1161/CIRCULATIONAHA.123.064521.
    PubMed     Abstract available

    June 2023
  31. CAPODANNO D, Mehran R, Krucoff MW, Baber U, et al
    Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
    Circulation. 2023;147:1933-1944.
    PubMed     Abstract available

    May 2023
  32. MAN S, Solomon N, Mac Grory B, Alhanti B, et al
    Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064053.
    PubMed     Abstract available

    April 2023
  33. OSZTROGONACZ P, Lumsden AB
    The SAFE-AAA Study: Is One Limb at a Time Better Than Two?
    Circulation. 2023;147:1277-1280.

  34. PARLOW S, Di Santo P, Abdel-Razek O, Jung RG, et al
    Utility of a Smartphone Application in Assessing Palmar Circulation Before Radial Artery Harvesting for Coronary Artery Bypass Grafting.
    Circulation. 2023;147:1183-1185.

    March 2023
  35. ASIF KS, Otite FO, Desai SM, Herial N, et al
    Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study.
    Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063366.
    PubMed     Abstract available

  36. HAN JK, Hwang D, Yang S, Park SH, et al
    Comparison Of 3-6 Month Versus 12 Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064264.
    PubMed     Abstract available

  37. SECEMSKY EA, Song Y, Sun T, Johnson CG, et al
    Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study.
    Circulation. 2023 Mar 3. doi: 10.1161/CIRCULATIONAHA.122.062123.
    PubMed     Abstract available

    February 2023
  38. COUGHLAN JJ, Raber L, Brugaletta S, Kufner S, et al
    Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation.
    Circulation. 2023;147:575-585.
    PubMed     Abstract available

    January 2023
  39. GOLDBERG JB, Giri J, Kobayashi T, Ruel M, et al
    Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Jan 23. doi: 10.1161/CIR.0000000000001117.
    PubMed     Abstract available

  40. CAPODANNO D, Angiolillo DJ
    Long-Term P2Y(12) Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention.
    Circulation. 2023;147:118-121.

    December 2022
  41. OBEL LM, Lindholt JS, Lasota AN, Jensen HK, et al
    Clinical Characteristics, Incidences, and Mortality Rates for Type A and B Aortic Dissections: A Nationwide Danish Population-Based Cohort Study From 1996 to 2016.
    Circulation. 2022;146:1903-1917.
    PubMed     Abstract available

  42. GYLDENKERNE C, Maeng M, Kjoller-Hansen L, Maehara A, et al
    Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061983.
    PubMed     Abstract available

    November 2022
  43. KANG J, Park KW, Lee H, Hwang D, et al
    Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study.
    Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062770.
    PubMed     Abstract available

  44. WU H, Xu L, Zhao X, Zhang H, et al
    Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-eluting Stent Implantation (OPTION): a Randomized, Open-label, Endpoint-blinded, Non-inferiority Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062762.
    PubMed     Abstract available

    October 2022
  45. RUEL M, Williams A
    A New Effect Modifier of the Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Decision: Physical and Mental Functioning.
    Circulation. 2022;146:1281-1283.

  46. GOLDMAN S, McCarren M, Sethi GK, Holman W, et al
    Long-Term Mortality Follow-Up of Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Grafting: A Multicenter, Randomized Trial.
    Circulation. 2022;146:1323-1325.

  47. GAUDINO M, Lytle B
    Right Internal Thoracic Artery for Coronary Bypass Surgery: Did We Get It Wrong?
    Circulation. 2022;146:1266-1267.

  48. ESCOBAR GA, Oderich GS, Farber MA, de Souza LR, et al
    Results of the North American Complex Abdominal Aortic Debranching (NACAAD) Registry.
    Circulation. 2022;146:1149-1158.
    PubMed     Abstract available

    September 2022
  49. MENTIAS A, Desai MY, Keshvani N, Gillinov AM, et al
    Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States.
    Circulation. 2022 Sep 26:101161CIRCULATIONAHA122059496.
    PubMed     Abstract available

  50. AHN JM, Kang DY, Yun SC, Hur SH, et al
    Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial.
    Circulation. 2022 Sep 19. doi: 10.1161/CIRCULATIONAHA.122.062188.
    PubMed     Abstract available

    August 2022
  51. BONACA MP, Morrow DA, Bergmark BA, Berg DD, et al
    Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
    Circulation. 2022 Aug 30:101161CIRCULATIONAHA122059325.
    PubMed     Abstract available

  52. GARGIULO G, Giacoppo D, Jolly SS, Cairns J, et al
    Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061527.
    PubMed     Abstract available

  53. RAO SV, Kirsch B, Bhatt DL, Budaj A, et al
    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
    Circulation. 2022 Aug 27. doi: 10.1161/CIRCULATIONAHA.122.061612.
    PubMed     Abstract available

  54. STABLES RH, Mullen LJ, Elguindy M, Nicholas Z, et al
    Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial.
    Circulation. 2022 Aug 10:101161CIRCULATIONAHA121057793.
    PubMed     Abstract available

    July 2022
  55. KRAWISZ AK, Natesan S, Wadhera RK, Chen S, et al
    Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention.
    Circulation. 2022;146:191-200.
    PubMed     Abstract available

  56. ONO M, Serruys PW, Garg S, Kawashima H, et al
    Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
    Circulation. 2022 Jul 18:101161CIRCULATIONAHA121057021.
    PubMed     Abstract available

    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.

    June 2022
  58. ABDELHALIM MA, Patel A, Moquet J, Saha P, et al
    Higher Incidence of Chromosomal Aberrations in Operators Performing a Large Volume of Endovascular Procedures.
    Circulation. 2022;145:1808-1810.

  59. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    PubMed     Abstract available

    May 2022
  60. SHISHEHBOR MH, Zeller T, Werner M, Brodmann M, et al
    Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
    Circulation. 2022;145:1645-1654.
    PubMed     Abstract available

  61. FEARON WF, Zimmermann FM, Ding VY, Zelis JM, et al
    Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Circulation. 2022;145:1655-1662.
    PubMed     Abstract available

    April 2022
  62. PATEL KK
    Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.
    Circulation. 2022;145:1308-1311.

  63. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed     Abstract available

  64. WHITE HD
    Zooming in on the Enigmas of Type 2 Myocardial Infarction.
    Circulation. 2022;145:1201-1204.

  65. SEIKE Y, Matsuda H, Shimizu H, Ishimaru S, et al
    Nationwide Analysis of Persistent Type II Endoleak and Late Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in Japan: A Propensity-Matched Analysis.
    Circulation. 2022;145:1056-1066.
    PubMed     Abstract available

    March 2022
  66. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available

  67. MAAMARI DJ, Jaffer FA, Khera AV, Fahed AC, et al
    CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?
    Circulation. 2022;145:721-723.

    February 2022
  68. DASHWOOD MR, Pinheiro BB, Souza DSR
    Thirty Years of No-Touch Saphenous Vein Harvesting: A Timely Jubilee Gift.
    Circulation. 2022;145:319-320.

    January 2022
  69. CHEW DS, Cowper PA, Al-Khalidi H, Anstrom KJ, et al
    Cost Effectiveness of Coronary-Artery Bypass Surgery versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
    Circulation. 2022 Jan 19. doi: 10.1161/CIRCULATIONAHA.121.056276.
    PubMed     Abstract available

  70. GRUBB KJ, Kirtane AJ
    The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
    Circulation. 2022;145:155-157.

    December 2021
  71. LAM CZ, Gulamhusein A, Wald RM
    Liver Cirrhosis and Hepatocellular Carcinoma After the Fontan Operation: Reaching Clarity in the Face of Uncertainty.
    Circulation. 2021;144:1977-1980.

  72. NII M, Inuzuka R, Inai K, Shimada E, et al
    Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.
    Circulation. 2021;144:2043-2045.

  73. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
    2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2021 Dec 9:CIR0000000000001039. doi: 10.1161/CIR.0000000000001039.
    PubMed     Abstract available

    October 2021
  74. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available

  75. DAHLE G, Kempfert J
    Fifty Years After the Introduction of Vein Grafts for CABG: New Evidence for a No-Touch Harvesting Approach.
    Circulation. 2021;144:1130-1132.

  76. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
    The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
    Circulation. 2021;144:1160-1171.
    PubMed     Abstract available

    September 2021
  77. EDGAR L, Akbar N, Braithwaite AT, Krausgruber T, et al
    Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis.
    Circulation. 2021;144:961-982.
    PubMed     Abstract available

  78. TIAN M, Wang X, Sun H, Feng W, et al
    No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.
    Circulation. 2021 Sep 13. doi: 10.1161/CIRCULATIONAHA.121.055525.

  79. KIM MS, Kim KB
    Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft: Ten-Year Angiographic and Long-Term Clinical Results of the SAVE RITA Trial.
    Circulation. 2021 Sep 8. doi: 10.1161/CIRCULATIONAHA.121.056438.

    August 2021
  80. XENOGIANNIS I, Zenati M, Bhatt DL, Rao SV, et al
    Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
    Circulation. 2021;144:728-745.
    PubMed     Abstract available

  81. WATERS DD, Stone GW
    Usefulness of Angina to Guide Revascularization Decisions.
    Circulation. 2021;144:524-527.

    July 2021
  82. MEHTA SR
    Achieving Complete Revascularization for Multivessel Coronary Artery Disease.
    Circulation. 2021;144:110-112.

    June 2021
  83. DECANO JL, Singh SA, Gasparotto Bueno C, Ho Lee L, et al
    Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARalpha Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.
    Circulation. 2021;143:2454-2470.
    PubMed     Abstract available

    May 2021
  84. TAKAHASHI K, Serruys PW, Gao C, Ono M, et al
    Ten-Year All-Cause Death According to Completeness of Revascularization in Patients with Three-Vessel Disease or Left Main Coronary Artery Disease: Insights from the SYNTAX Extended Survival Study.
    Circulation. 2021 May 20. doi: 10.1161/CIRCULATIONAHA.120.046289.
    PubMed     Abstract available

    April 2021
  85. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
    Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
    PubMed     Abstract available

  86. SHAH R
    Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e807-e808.

    March 2021
  87. VERRALL CE, Yang JYM, Chen J, Schembri A, et al
    Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults With a Fontan Circulation.
    Circulation. 2021;143:878-891.
    PubMed     Abstract available

    February 2021
  88. ANGIOLILLO DJ, Bhatt DL, Cannon CP, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Circulation. 2021;143:583-596.
    PubMed     Abstract available

    January 2021
  89. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    PubMed     Abstract available

  90. O'FEE K, Panza JA, Brown DL
    Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
    Circulation. 2021;143:205-207.

    December 2020
  91. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.

  92. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.

  93. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.

  94. IGLESIAS JF, Valgimigli M, Carbone F, Lauriers N, et al
    Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.
    Circulation. 2020;142:2479-2481.

  95. VLACHOJANNIS GJ, Wilschut JM, Vogel RF, Lemmert ME, et al
    Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
    Circulation. 2020;142:2316-2328.
    PubMed     Abstract available

  96. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    PubMed     Abstract available

  97. CHAITMAN BR, Alexander KP, Cyr DD, Berger JS, et al
    Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.047987.
    PubMed     Abstract available

    November 2020
  98. KIM HS, Kang J, Hwang D, Han JK, et al
    Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
    Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.051700.
    PubMed     Abstract available

  99. ALEXANDER JH, Smith PK
    Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1797-1798.

    October 2020
  100. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available

  101. FRANCHI F, Rollini F, Been L, Briceno M, et al
    Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
    Circulation. 2020;142:1500-1502.

  102. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    PubMed     Abstract available

  103. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
    Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
    Circulation. 2020;142:1399-1401.

  104. LYTLE B, Gaudino M
    Fractional Flow Reserve for Coronary Artery Bypass Surgery.
    Circulation. 2020;142:1315-1316.

    August 2020
  105. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e76-e77.

  106. VINCENT F, Van Belle E, Susen S
    Letter by Vincent et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e80-e81.

  107. O'NEILL WW, Burkhoff D
    Letter by O'Neill and Burkhoff Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e78-e79.

  108. HELGESTAD OKL, Moller S, Moller JE
    Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e72-e73.

  109. AMIN AP, Rao SV, Bach RG, Curtis JP, et al
    Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e82-e84.

  110. CHIEFFO A, Gramegna M, Pappalardo F
    Letter by Chieffo et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e74-e75.

  111. GARGIULO G, Esposito G, Avvedimento M, Nagler M, et al
    Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:441-454.
    PubMed     Abstract available

  112. KHAN SU, Singh M, Valavoor S, Khan MU, et al
    Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
    Circulation. 2020 Aug 3. doi: 10.1161/CIRCULATIONAHA.120.046308.
    PubMed     Abstract available

    July 2020
  113. FARIDI KF, Tamez H, Strom JB, Song Y, et al
    Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
    Circulation. 2020;142:306-308.

    June 2020
  114. COLLERAN R, Byrne RA
    Polymer-Free Drug-Eluting Stents: The Importance of the Right Control.
    Circulation. 2020;141:2064-2066.

  115. O'DONOGHUE ML, Murphy SA, Sabatine MS
    The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Circulation. 2020 Jun 19. doi: 10.1161/CIRCULATIONAHA.120.046251.
    PubMed     Abstract available

  116. CHANDRASHEKHAR Y, Alexander T, Mullasari A, Kumbhani DJ, et al
    Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries.
    Circulation. 2020;141:2004-2025.
    PubMed     Abstract available

  117. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    PubMed     Abstract available

    May 2020
  118. NAVARESE EP, Khan SU, Kolodziejczak M, Kubica J, et al
    Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.120.046786.
    PubMed     Abstract available

  119. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    PubMed     Abstract available

    March 2020
  120. PARK DW, Ahn JM, Park H, Yun SC, et al
    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046039.

  121. ALFONSO F, Kastrati A
    Ten-Year Follow-Up of Left Main Coronary Artery Revascularization: Still Equipoise Between Percutaneous Interventions and Surgery?
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046154.

  122. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.